These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma. Benzaquen M Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547 [TBL] [Abstract][Full Text] [Related]
4. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma. Ascierto PA; Schadendorf D J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma. Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660 [TBL] [Abstract][Full Text] [Related]
6. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948 [TBL] [Abstract][Full Text] [Related]
7. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma. Hernández-Guerrero T; Doger B; Moreno V Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085 [TBL] [Abstract][Full Text] [Related]
8. Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma. Giri A; Bauman JR Expert Rev Anticancer Ther; 2022 Oct; 22(10):1029-1038. PubMed ID: 36106496 [TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma. Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954 [TBL] [Abstract][Full Text] [Related]
10. Systemic therapy for advanced cutaneous squamous cell carcinoma. Fitzgerald K; Tsai KK Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028 [TBL] [Abstract][Full Text] [Related]
11. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149 [TBL] [Abstract][Full Text] [Related]
12. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios. Akhtar K; Sravanthi MV; D'Angelo J; Sivapiragasam A J Investig Med High Impact Case Rep; 2022; 10():23247096221121408. PubMed ID: 36017984 [TBL] [Abstract][Full Text] [Related]